186 related articles for article (PubMed ID: 23741347)
21. A rare connection: fasciculoventricular pathway in PRKAG2 disease.
Govindan M; Ward D; Behr E
J Cardiovasc Electrophysiol; 2010 Mar; 21(3):329-32. PubMed ID: 19732236
[TBL] [Abstract][Full Text] [Related]
22. Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.
Ramratnam M; Sharma RK; D'Auria S; Lee SJ; Wang D; Huang XY; Ahmad F
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25092788
[TBL] [Abstract][Full Text] [Related]
23. PRKAG2 mutations presenting in infancy.
Torok RD; Austin SL; Phornphutkul C; Rotondo KM; Bali D; Tatum GH; Wechsler SB; Buckley AF; Kishnani PS
J Inherit Metab Dis; 2017 Nov; 40(6):823-830. PubMed ID: 28801758
[TBL] [Abstract][Full Text] [Related]
24. Controversial molecular functions of CBS versus non-CBS domain variants of PRKAG2 in arrhythmia and cardiomyopathy: A case report and literature review.
Gong X; Yu P; Wu T; He Y; Zhou K; Hua Y; Lin S; Wang T; Huang H; Li Y
Mol Genet Genomic Med; 2022 Jul; 10(7):e1962. PubMed ID: 35588295
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a PRKAG2 cardiac syndrome disease model and mechanism study using human induced pluripotent stem cells.
Zhan Y; Sun X; Li B; Cai H; Xu C; Liang Q; Lu C; Qian R; Chen S; Yin L; Sheng W; Huang G; Sun A; Ge J; Sun N
J Mol Cell Cardiol; 2018 Apr; 117():49-61. PubMed ID: 29452156
[TBL] [Abstract][Full Text] [Related]
26. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
27. Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation.
Kelly BP; Russell MW; Hennessy JR; Ensing GJ
Pediatr Cardiol; 2009 Nov; 30(8):1176-9. PubMed ID: 19787389
[TBL] [Abstract][Full Text] [Related]
28. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
[TBL] [Abstract][Full Text] [Related]
29. Cardiac manifestations of PRKAG2 mutation.
Banankhah P; Fishbein GA; Dota A; Ardehali R
BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
[TBL] [Abstract][Full Text] [Related]
30. Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome.
Xie C; Zhang YP; Song L; Luo J; Qi W; Hu J; Lu D; Yang Z; Zhang J; Xiao J; Zhou B; Du JL; Jing N; Liu Y; Wang Y; Li BL; Song BL; Yan Y
Cell Res; 2016 Oct; 26(10):1099-1111. PubMed ID: 27573176
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.
Thevenon J; Laurent G; Ader F; Laforêt P; Klug D; Duva Pentiah A; Gouya L; Maurage CA; Kacet S; Eicher JC; Albuisson J; Desnos M; Bieth E; Duboc D; Martin L; Réant P; Picard F; Bonithon-Kopp C; Gautier E; Binquet C; Thauvin-Robinet C; Faivre L; Bouvagnet P; Charron P; Richard P
Europace; 2017 Apr; 19(4):651-659. PubMed ID: 28431061
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
[TBL] [Abstract][Full Text] [Related]
33. Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation.
Banerjee SK; McGaffin KR; Huang XN; Ahmad F
Biochim Biophys Acta; 2010 Feb; 1802(2):284-91. PubMed ID: 20005292
[TBL] [Abstract][Full Text] [Related]
34. Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.
Murphy RT; Mogensen J; McGarry K; Bahl A; Evans A; Osman E; Syrris P; Gorman G; Farrell M; Holton JL; Hanna MG; Hughes S; Elliott PM; Macrae CA; McKenna WJ
J Am Coll Cardiol; 2005 Mar; 45(6):922-30. PubMed ID: 15766830
[TBL] [Abstract][Full Text] [Related]
35. [Same genotype and different phenotypes in a family with PRKAG2 gene mutation].
Hong K; Oliva A; Cheng XS; Brugada P; Brugada J; Sternick EB; Brugada R
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):552-4. PubMed ID: 17711718
[TBL] [Abstract][Full Text] [Related]
36. Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome.
Fabris E; Brun F; Porto AG; Losurdo P; Vitali Serdoz L; Zecchin M; Severini GM; Mestroni L; Di Chiara A; Sinagra G
J Am Coll Cardiol; 2013 Aug; 62(9):e17. PubMed ID: 23810891
[No Abstract] [Full Text] [Related]
37. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
[TBL] [Abstract][Full Text] [Related]
38. A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.
Laforêt P; Richard P; Said MA; Romero NB; Lacene E; Leroy JP; Baussan C; Hogrel JY; Lavergne T; Wahbi K; Hainque B; Duboc D
Neuromuscul Disord; 2006 Mar; 16(3):178-82. PubMed ID: 16487706
[TBL] [Abstract][Full Text] [Related]
39. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.
Akman HO; Sampayo JN; Ross FA; Scott JW; Wilson G; Benson L; Bruno C; Shanske S; Hardie DG; Dimauro S
Pediatr Res; 2007 Oct; 62(4):499-504. PubMed ID: 17667862
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic expression and clinical outcomes in a South Asian PRKAG2 cardiomyopathy cohort.
Ahamed H; Balegadde AV; Menon S; Menon R; Ramachandran A; Mathew N; Natarajan KU; Nair IR; Kannan R; Shankar M; Mathew OK; Nguyen TT; Gupta R; Stawiski EW; Ramprasad VL; Seshagiri S; Phalke S
Sci Rep; 2020 Nov; 10(1):20610. PubMed ID: 33244021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]